Evgen Pharma is a clinical stage drug development company focused on cancer and neurological disease. Our pipeline is based on our proprietary Sulforadex® technology, and includes a number of synthetic, stabilised analogues of the naturally occurring compound sulforaphane. Many peer-reviewed scientific papers have identified the medical potential of sulforaphane in multiple indications. Our objective is to use our Sulforadex® technology to turn this scientific promise into commercially successful products, addressing important clinical needs.
View Top Employees from Evgen Pharma| Website | http://www.evgen.com |
| Ticker | EVG |
| Revenue | $1 million |
| Employees | 7 (6 on RocketReach) |
| Founded | 2007 |
| Phone | +44 1625 466591 |
| Technologies |
JavaScript,
HTML,
PHP
+25 more
(view full list)
|
| Industry | Pharmaceutical Manufacturing, Manufacturing General, Biotechnology, Pharmaceuticals, Manufacturing, Science and Engineering, Cancer and neurological conditions, Medical, Core technology Sulforadex®, Health Care, Commercialising sulforaphane-based pharmaceuticals, Pharmaceutical |
| Web Rank | 13 Million |
| Competitors | BioLineRx, Can Fite BioPharma (CANFY), Pherin Pharmaceuticals, Inc., Sun BioPharma, Vidac Pharma |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 32 Companies, NAICS Code 32541 Companies, NAICS Code 3254 Companies, NAICS Code 325 Companies |
Looking for a particular Evgen Pharma employee's phone or email?
Evgen Pharma Questions
The Evgen Pharma annual revenue was $1 million in 2024.
Glen Clack is the Chief Medical Officer of Evgen Pharma.
6 people are employed at Evgen Pharma.
The NAICS codes for Evgen Pharma are [32, 32541, 3254, 325].
The SIC codes for Evgen Pharma are [283, 28].
Top Evgen Pharma Employees
-
31
-
2
-
1
-
55+
Related Companies
